Skip to content

Prevalence of Peripheral Vascular Diseases and Presentation in Patients With Autoimmune Diseases

Prevalence of Peripheral Vascular Diseases and Presentation in Patients With Autoimmune Diseases

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06169865
Enrollment
300
Registered
2023-12-14
Start date
2023-09-10
Completion date
2024-05-10
Last updated
2023-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Vascular Diseases and Presentation in Patient With Autoimmune Diseases

Brief summary

Rheumatic autoimmune diseases include conditions such as systemic lupus rheumatoid arthritis systemic sclerosis in which connective tissues are frequently targeted. Autoimmune diseases as a group are among the leading causes of death and morbidity in the industrial world and pose an immense socioeconomic burden despite the considerable accumulative burden of these diseases only a small number of multinational registries for a few selected autoimmune diseases have been devised. Numerous autoimmune inflammatory diseases have been associated with various forms of vasculopathy and increase vascular disease risk such as accelerated atherogenesis and thromboembolic events as digital and acral gangrene secondary Raynaud syndrome arterial aneurysm and different cutaneous ulcer. The etiopathogenesis os increased risk of peripheral vascular diseases and presentation in autoimmune diseases is not entirely clear but multiple contibutors have been explored especially in the context of systemic inflammation and disordered thrombogenesis.

Interventions

cross sectional study to explore magnitude of peripheral vascular diseases and presentations in patients with autoimmune diseases in sohag society.

Sponsors

Hossam Adly Mohamed
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL

Inclusion criteria

* all ages * Both sexes * Recent or past history of vascular diseases or presentation in any proven autoimmune diseases according to the guidlines.

Exclusion criteria

* patients refuse the study * patients do not have established diagnosis of vascular diseases . * patients not completely approved to have autoimmune diseases.

Design outcomes

Primary

MeasureTime frameDescription
prevalence of peripheral vascular diseases and presentations in patients with autoimmune diseases .6 monthsold and new vascular diseases and presentations in patients with autoimmune diseases

Countries

Egypt

Contacts

Primary Contacthosam A Mohamed, resident
hosamadly@med.sohag.edu.eg01023012244
Backup ContactAhmed s Abd Alfatah, assistant professor
01096495577

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026